Literature DB >> 15464423

Death effectors of beta-cell apoptosis in type 1 diabetes.

Myung-Shik Lee1, Inik Chang, Sunshin Kim.   

Abstract

While it is generally agreed that apoptosis of pancreatic beta-cells is the most important and final step in the progression of type 1 diabetes without which clinical diabetes does not develop, it has not been elucidated which molecule(s) are the real culprit(s) in type 1 diabetes. Perforin, FasL, TNFalpha, IL-1, IFNgamma, and NO have been claimed as the effector molecules; however, they, as a single agent, might explain only part of beta-cell death in type 1 diabetes. While FasL was initially considered as a strong candidate for the most important death effector, following experiments cast doubt on such a hypothesis. Combinations or synergism between IFNgamma and TNFalpha or IL-1beta are being revisited as the death effectors, and molecular mechanism explaining such a synergism was addressed in several recent papers. The role of NF-kappaB for pancreatic beta-cell death in type 1 diabetes is also controversial. While NF-kappaB plays anti-apoptotic roles in most other death models, its role in type 1 diabetes might be different probably due to the involvement of multiple cytokines at different stages of the disease progression and the peculiarity of pancreatic beta-cells. Recent papers also suggested a role for Ca2+ in cytokine-mediated pancreatic beta-cell death. Such participation of Ca2+ in beta-cell death appears to have a close relevance to the mitochondrial events or ER stress that constitutes an important part of cell death machinery recently identified.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15464423     DOI: 10.1016/j.ymgme.2004.08.002

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  18 in total

Review 1.  Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.

Authors:  Xiaolun Huang; Daniel J Moore; Robert J Ketchum; Craig S Nunemaker; Boris Kovatchev; Anthony L McCall; Kenneth L Brayman
Journal:  Endocr Rev       Date:  2008-07-29       Impact factor: 19.871

Review 2.  The central role of calcium in the effects of cytokines on beta-cell function: implications for type 1 and type 2 diabetes.

Authors:  James W Ramadan; Stephen R Steiner; Christina M O'Neill; Craig S Nunemaker
Journal:  Cell Calcium       Date:  2011-09-23       Impact factor: 6.817

3.  AGI-1067, a novel antioxidant and anti-inflammatory agent, enhances insulin release and protects mouse islets.

Authors:  William S Crim; Runpei Wu; Jeffrey D Carter; Banumathi K Cole; Anthony P Trace; Raghavendra G Mirmira; Charles Kunsch; Jerry L Nadler; Craig S Nunemaker
Journal:  Mol Cell Endocrinol       Date:  2010-03-06       Impact factor: 4.102

4.  Human placental lactogen (hPL-A) activates signaling pathways linked to cell survival and improves insulin secretion in human pancreatic islets.

Authors:  Marco F Lombardo; Fabiana De Angelis; Luca Bova; Barbara Bartolini; Federico Bertuzzi; Rita Nano; Barbara Capuani; Renato Lauro; Massimo Federici; Davide Lauro; Giulia Donadel
Journal:  Islets       Date:  2011-09-01       Impact factor: 2.694

5.  Regulation of CCAAT/enhancer-binding protein homologous protein (CHOP) expression by interleukin-1 beta in pancreatic beta cells.

Authors:  Chunli Shao; Michael C Lawrence; Melanie H Cobb
Journal:  J Biol Chem       Date:  2010-04-27       Impact factor: 5.157

Review 6.  Non-receptor tyrosine kinase signaling in autoimmunity and therapeutic implications.

Authors:  Sabrina Solouki; Avery August; Weishan Huang
Journal:  Pharmacol Ther       Date:  2019-05-11       Impact factor: 12.310

7.  Evidence that low-grade systemic inflammation can induce islet dysfunction as measured by impaired calcium handling.

Authors:  Stacey B Dula; Mladen Jecmenica; Runpei Wu; Pooya Jahanshahi; Gretchen M Verrilli; Jeffrey D Carter; Kenneth L Brayman; Craig S Nunemaker
Journal:  Cell Calcium       Date:  2010-08-25       Impact factor: 6.817

Review 8.  Neutralization Versus Reinforcement of Proinflammatory Cytokines to Arrest Autoimmunity in Type 1 Diabetes.

Authors:  Ayelet Kaminitz; Shifra Ash; Nadir Askenasy
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

Review 9.  A link between endoplasmic reticulum stress-induced β-cell apoptosis and the group VIA Ca2+-independent phospholipase A2 (iPLA2β).

Authors:  X Lei; S Zhang; B Emani; S E Barbour; S Ramanadham
Journal:  Diabetes Obes Metab       Date:  2010-10       Impact factor: 6.577

10.  Mouse vanin-1 is cytoprotective for islet beta cells and regulates the development of type 1 diabetes.

Authors:  C Roisin-Bouffay; R Castellano; R Valéro; L Chasson; F Galland; P Naquet
Journal:  Diabetologia       Date:  2008-05-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.